Cargando…
Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults
The objective of this study was to assess the association between dietary patterns and risk of hepatocellular carcinoma (HCC) among US adults in a hospital-based case-control study. We analyzed data from 641 cases and 1002 controls recruited at The University of Texas MD Anderson Cancer Center durin...
Autores principales: | Moussa, Iman, Day, Rena S., Li, Ruosha, Du, Xianglin L., Kaseb, Ahmed O., Jalal, Prasun K., Daniel-MacDougall, Carrie, Hatia, Rikita I., Abdelhakeem, Ahmed, Rashid, Asif, Chun, Yun Shin, Li, Donghui, Hassan, Manal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230753/ https://www.ncbi.nlm.nih.gov/pubmed/34208122 http://dx.doi.org/10.3390/nu13062011 |
Ejemplares similares
-
Association of dietary fat intake and hepatocellular carcinoma among US adults
por: Moussa, Iman, et al.
Publicado: (2021) -
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
por: Mohamed, Yehia I., et al.
Publicado: (2022) -
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023) -
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023) -
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Mohamed, Yehia I., et al.
Publicado: (2021)